hhs

  • Bio
    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technology centers around the enzyme Cas9, which acts as a type of genetic scissors, allowing scientists to snip out, edit and replace DNA at certain intervals along the genome. However, Cas3 goes beyond… Read More

  • Behind Healthcare.gov: How Washington Is Drawing Inspiration From Silicon Valley, Twitter

    “We were working 24/7, working in very, very rapid cycles, with very, very short deadlines and milestones. We were working in a very, very nimble hyper consumer focused way…all fused in this kind of maelstrom of pizza, Mountain Dew, and all nighters, and you know idealism.” That may sound like the caffeine-fueled, sleep-deprived rant of a typical Silicon Valley entrepreneur. Read More